8-18222237-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_000662.8(NAT1):c.190C>T(p.Arg64Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00574 in 1,614,042 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0036 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0060 ( 33 hom. )
Consequence
NAT1
NM_000662.8 missense
NM_000662.8 missense
Scores
5
3
11
Clinical Significance
Conservation
PhyloP100: 0.833
Publications
49 publications found
Genes affected
NAT1 (HGNC:7645): (N-acetyltransferase 1) This gene is one of two arylamine N-acetyltransferase (NAT) genes in the human genome, and is orthologous to the mouse and rat Nat2 genes. The enzyme encoded by this gene catalyzes the transfer of an acetyl group from acetyl-CoA to various arylamine and hydrazine substrates. This enzyme helps metabolize drugs and other xenobiotics, and functions in folate catabolism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.021713734).
BP6
Variant 8-18222237-C-T is Benign according to our data. Variant chr8-18222237-C-T is described in ClinVar as Benign. ClinVar VariationId is 252546.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 547 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NAT1 | NM_000662.8 | c.190C>T | p.Arg64Trp | missense_variant | Exon 3 of 3 | ENST00000307719.9 | NP_000653.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NAT1 | ENST00000307719.9 | c.190C>T | p.Arg64Trp | missense_variant | Exon 3 of 3 | 1 | NM_000662.8 | ENSP00000307218.4 |
Frequencies
GnomAD3 genomes AF: 0.00360 AC: 547AN: 152096Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
547
AN:
152096
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00335 AC: 841AN: 251168 AF XY: 0.00347 show subpopulations
GnomAD2 exomes
AF:
AC:
841
AN:
251168
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00596 AC: 8714AN: 1461828Hom.: 33 Cov.: 32 AF XY: 0.00570 AC XY: 4148AN XY: 727218 show subpopulations
GnomAD4 exome
AF:
AC:
8714
AN:
1461828
Hom.:
Cov.:
32
AF XY:
AC XY:
4148
AN XY:
727218
show subpopulations
African (AFR)
AF:
AC:
42
AN:
33472
American (AMR)
AF:
AC:
59
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
26134
East Asian (EAS)
AF:
AC:
0
AN:
39696
South Asian (SAS)
AF:
AC:
31
AN:
86254
European-Finnish (FIN)
AF:
AC:
114
AN:
53416
Middle Eastern (MID)
AF:
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
8192
AN:
1111980
Other (OTH)
AF:
AC:
274
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
519
1038
1558
2077
2596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
318
636
954
1272
1590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00359 AC: 547AN: 152214Hom.: 1 Cov.: 32 AF XY: 0.00314 AC XY: 234AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
547
AN:
152214
Hom.:
Cov.:
32
AF XY:
AC XY:
234
AN XY:
74430
show subpopulations
African (AFR)
AF:
AC:
43
AN:
41534
American (AMR)
AF:
AC:
10
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
21
AN:
10596
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
466
AN:
68014
Other (OTH)
AF:
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
31
ALSPAC
AF:
AC:
37
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
67
ExAC
AF:
AC:
379
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Dec 17, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;.;T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Pathogenic
.;D;.;.;D;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H;H;H;H;.;H
PhyloP100
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D;D;D;D;D
REVEL
Benign
Sift
Pathogenic
D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D
Polyphen
D;D;D;D;D;D
Vest4
MVP
MPC
0.12
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.